The Future of Diagnosing and Treating Autoimmune Diseases

5 June, 10:00–11:30 Congress Centre, zone B, 2nd floor, conference hall B3
Broadcast
Autoimmune diseases remain one of the biggest challenges in the medical world and pose a serious burden for the economy due to the high risk of disability and the poor prognosis for patients. Epidemiological studies show that the most common autoimmune disease is type 1 diabetes, which generally appears in childhood. At present, the causative factor of autoimmune diseases is only known in isolated cases, and most treatment strategies simply aim to contain symptoms and complications. The scientific and medical knowledge that has been gained in such areas as immunology and genetically engineered biological and cell therapy is now bringing scientists closer to understanding the causes of autoimmune destruction, which will make it possible to correctly verify the diagnosis and find fundamentally new therapeutic approaches to the effective treatment of a wide range of autoimmune diseases. How are innovative discoveries in autoimmunology changing the face of pharmacotherapy for autoimmune diseases today? What opportunities does personalized medicine offer for the diagnosis and treatment of autoimmune diseases? Can breakthrough solutions in the treatment of autoimmune diseases be integrated into practical healthcare? How close is medical science to understanding the causes of type 1 diabetes, which threatens children’s health?

Broadcast

Image